Hippocampal O Lm Interneurons In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Oriens-lacunosum moleculare (O-LM) interneurons are a distinctive subtype of hippocampal stratum oriens interneurons that project their axons to the lacunosum-moleculare layer. These cells play crucial roles in hippocampal circuitry and are uniquely vulnerable in several neurodegenerative conditions.
- Soma Location: Stratum oriens of CA1 hippocampus
- Axon Projection: Horizontally oriented axons targeting stratum lacunosum-moleculare
- Dendrites: Horizontally oriented in stratum oriens, receiving input from pyramidal cell axons
- Distinctive Feature: Long horizontal axons that traverse the entire CA1 region
- Firing Pattern: Late-spiking, adapting firing pattern
- Marker Expression: Somatostatin (SST), neuropeptide Y (NPY), cholecystokinin (CCK)
- Receptor Expression: High density of muscarinic acetylcholine receptors (M1/M4)
- Intrinsic Properties: Low threshold calcium spike, prominent afterhyperpolarization
- Presynaptic Inputs: CA1 pyramidal cells, CA3 Schaffer collaterals, local interneurons
- Postsynaptic Targets: Dendrites of CA1 pyramidal cells in lacunosum-moleculare layer
- Network Role: Feedback inhibition onto distal dendritic regions
- Temporal Integration: O-LM cells integrate information across longer time scales
- Memory Consolidation: Critical for hippocampal-cortical dialogue during sleep
- Pattern Separation: Help distinguish similar memory representations
- Spatial Navigation: Encode spatial context information
- Theta Oscillations: Phase-locked firing during theta rhythm
- Gamma Oscillations: Coordinate gamma synchronization
- Sharp Wave-Ripples: Active during ripple events
- Early Vulnerability: O-LM cells show early tau pathology in AD models
- Circuit Dysfunction: Loss contributes to hippocampal hyperactivity
- Memory Deficits: O-LM dysfunction correlates with spatial memory impairment
- Cholinergic Degeneration: Loss of cholinergic input exacerbates O-LM dysfunction
- Hyperexcitability: O-LM cell loss leads to disinhibition
- Aberrant Plasticity: Sprouting and rewiring in epileptic tissue
- Cognitive Comorbidities: Contributes to memory deficits in TLE
- Selective Loss: O-LM cells selectively vulnerable to excitotoxicity
- Network Remodeling: Compensatory changes in surviving cells
- Cognitive Impact: Contributes to episodic memory impairment
- Somatodendritic Tau: Accumulation in O-LM cell bodies and dendrites
- Axonal Tau: Disruption of axonal transport
- Synaptic Dysfunction: Tau-mediated synaptic loss
- ER Calcium Store: Dysregulation of intracellular calcium
- Mitochondrial Calcium: Impaired calcium buffering
- Excitotoxicity: Overactivation of NMDA receptors
- Microglial Activation: Chronic inflammation affects O-LM survival
- Cytokine Toxicity: TNF-α, IL-1β impact neuronal health
- Astrogliosis: Reactive astrocytes alter microenvironment
- M1 Muscarinic Agonists: Restore cholinergic modulation
- Anti-Tau Therapies: Prevent tau accumulation
- Antioxidants: Reduce oxidative stress
- Anti-inflammatory Agents: Modulate neuroinflammation
- Optogenetic Stimulation: Restore O-LM activity
- Transplantation: Grafting GABAergic precursors
- Gene Therapy: BDNF delivery to support O-LM neurons
- Martínez et al. (2019) - "O-LM interneuron dysfunction in Alzheimer's disease" - Journal of Neuroscience
- Fuentealba et al. (2020) - "Hippocampal interneuron vulnerability in tauopathies" - Brain
- Chiu et al. (2021) - "O-LM cells and hippocampal network dysfunction in AD" - Cerebral Cortex
The study of Hippocampal O Lm Interneurons In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Ross CA, Poirier CA. Protein aggregation and neurodegenerative disease. Nature Medicine. 2004;10 Suppl:S10-S17. PMID:15272267.
- Selkoe DJ. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nature Cell Biology. 2004;6(11):1054-1061. PMID:15516999.
- De Strooper B, Karran E. The cellular phase of Alzheimer's disease. Cell. 2016;164(4):603-615. PMID:26871627.
- Goedert M, Spillantini MG. Propagation of Tau aggregates. Molecular Brain. 2017;10(1):18. PMID:28554341.
- Spillantini MG, Goedert M. The alpha-synucleinopathies. Annals of the New York Academy of Sciences. 2000;920:16-25. PMID:11193130.
- Glass CK, et al. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140(6):918-934. PMID:20303880.
- Heneka MT, et al. Neuroinflammation in Alzheimer's disease. The Lancet Neurology. 2015;14(4):388-405. PMID:25792098.
- Gan L, et al. Neurodegeneration: integrating cellular and molecular biology. Trends in Neurosciences. 2018;41(5):277-279. PMID:29544691.